Keefe Bruyette raises target for Marsh & McLennan stock to USD 201

Published on 10/19/2026 at 10:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The firm lifted its target from USD 186 to USD 201 on October 17, 2026. Marsh & McLennan stock costs EUR 169.40 on October 19, 2026 at Lang & Schwarz.

Target and earnings context

Keefe Bruyette raised its Marsh & McLennan target from USD 186 to USD 201 on October 17, 2026.
Third-quarter 2026 revenue reached USD 6.86 billion, up 8.00 percent year over year.
Marsh & McLennan stock trades at EUR 169.40 at 10:12 a.m. CEST at Lang & Schwarz on October 19, 2026.

Flatlay-Anordnung mit Zertifikat, ISIN-Karte, Lupe und Risikodiagramm auf Holztisch — Marsh & McLennan (ISIN US5717481023) präsentiert als Flatlay mit Aktienzertifikat, ISIN-Karte und Risikobewertungs-Utensilien, Illustration mit AI erstellt.

Marsh & McLennan (ISIN US5717481023) is trading at EUR 169.40 at Lang & Schwarz on October 19, 2026 at 10:12 a.m. CEST, while Keefe Bruyette raised its price target from USD 186 to USD 201 on October 17, 2026. The firm kept a Market Perform rating and pointed to large-account pricing nearing a bottom, alongside softer middle-market and small-account conditions into 2027, according to Markets Insider.

Third-quarter figures reset the debate

The target revision followed Marsh's third-quarter report dated October 15, 2026. Consolidated revenue rose 8.00 percent year over year to USD 6.86 billion, while adjusted earnings per share increased 10.00 percent to USD 2.03, according to MarketScreener. Net income attributable to the company was USD 808 million, and reported earnings per share were USD 1.69.

The comparison with expectations was also favorable. Adjusted earnings per share exceeded the USD 1.96 consensus by USD 0.07, while revenue was above the USD 6.64 billion estimate, according to MarketBeat. For investors, the key issue is whether the earnings improvement can offset the pricing pressure highlighted by Keefe Bruyette.

What does the target imply?

The analyst timeline shows a divided view after the results. UBS raised its target from USD 216 to USD 222 on October 6, 2026, while Keefe Bruyette's newer USD 201 target remained below that level, according to MarketBeat. That spread puts operating execution and insurance pricing at the center of the stock discussion.

Three dates frame the move

On October 6, 2026, UBS moved its target to USD 222 from USD 216; on October 15, 2026, Marsh reported USD 6.86 billion of third-quarter revenue; on October 17, 2026, Keefe Bruyette raised its target to USD 201 from USD 186. The next dated corporate event is the November 13, 2026 dividend payment, with a USD 0.99 quarterly dividend, according to MarketBeat.

Stock price and investor reference

Marsh & McLennan's primary listing is on the NYSE under MRSH. The company operates across risk, reinsurance, people and investments, and management consulting, giving the quarterly revenue mix more than one operating driver.

Marsh & McLennan stock was trading at EUR 169.40 at Lang & Schwarz on October 19, 2026 at 10:12 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Marsh & McLennan stock.